Dominick Colangelo sold $833k of VCEL
President and CEO at Vericel Corp. 24,397 shares at an average of $34.14, traded Dec 6, 2023, filed Dec 8, 2023.
Score components
- +25RoleCEO
- +23Trade size$833k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -4.0%, 3m +33.5%, 6m +31.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-23-056971, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 6, 2023 | MOption exercise Common Stock10b5-1 | +12,397 | $3.57 | $44k | 189,139 | Dec 8, 2023 |
| Dec 6, 2023 | SOpen-market sale Common Stock10b5-1 | -12,397 | $34.43 | $427k | 176,742 | Dec 8, 2023 |
| Dec 7, 2023 | MOption exercise Common Stock10b5-1 | +12,000 | $3.57 | $43k | 188,742 | Dec 8, 2023 |
| Dec 7, 2023 | SOpen-market sale Common Stock10b5-1 | -12,000 | $33.84 | $406k | 176,742 | Dec 8, 2023 |
| Dec 6, 2023 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +12,397 | $0.00 | $0 | 36,000 | Dec 8, 2023 |
| Dec 7, 2023 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +12,000 | $0.00 | $0 | 24,000 | Dec 8, 2023 |
Related signals
Other insiders at Vericel Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 19Weak | Vericel Corp | Kevin F McLaughlin director | $312k 7,000 shares | -28% | |
| 27Weak | Vericel Corp | Michael Halpin Chief Operating Officer | $468k 10,000 shares | -38% | |
| 27Weak | Vericel Corp | Jonathan Siegal Principal Accounting Officer | $220k 4,500 shares | -175% | |
| 36Weak | Vericel Corp | Sean C. Flynn Chief Legal Officer | $685k 15,000 shares | -90% | |
| 17Weak | Vericel Corp | Jonathan Mark Hopper Chief Medical Officer | $450k 10,000 shares | -12% | |
| 34Weak | Vericel Corp | Joseph Anthony Mara Jr Chief Financial Officer | $224k 5,000 shares | -24% | |
| 25Weak | Vericel Corp | Jonathan Siegal Principal Accounting Officer | $123k 2,732 shares | -244% | |
| 34Weak | Vericel Corp | Sean C. Flynn Chief Legal Officer | $603k 15,000 shares | -90% | |
| 26Weak | Vericel Corp | Michael Halpin Chief Operating Officer | $402k 10,000 shares | -38% | |
| 0Weak | Vericel Corp | Jonathan Mark Hopper Chief Medical Officer | $153k 4,375 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.